A adesão terapêutica no transtorno bipolar
DOI:
https://doi.org/10.25118/2763-9037.2011.v1.876Palavras-chave:
adesão terapêutica, transtorno bipolar, intervenções psicossociaisResumo
A adesão terapêutica é um importante problema para o tratamento das doenças crônicas. No transtorno bipolar, a não-adesão terapêutica contribui para o abismo entre a eficácia e efetividade do tratamento desses pacientes. A ausência de adesão terapêutica é freqüente no transtorno bipolar com estudos demonstrando taxas de até 50% de não-adesão em pacientes americanos. Múltiplos fatores foram associados a não-adesão no transtorno bipolar. Dentre eles pode-se destacar os sócio-demográficos, as atitudes diante a doença/tratamento e os fatores relacionados especificamente com o tratamento. Apesar disso, a mensuração da não-adesão terapêutica é um grande desafio, com instrumentos que não conseguem garantir uma boa acurácia. Por último , o uso de intervenções psicossociais, podem melhorar a adesão terapêutica dos pacientes portadores do transtorno bipolar.
Downloads
Métricas
Referências
.1. Altman S, Haeri S, Cohen LJ, et al. Predictors of relapse in bipolar disorder: a review. J Psychiatr Pract, 2006; 12(5):269-282. DOI: https://doi.org/10.1097/00131746-200609000-00002
• 2. Baldessarini RJ, Tondo L, Davis P, et al. Decreased risk of suicides ad attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord, 2006; 8(5): 625-639. DOI: https://doi.org/10.1111/j.1399-5618.2006.00344.x
• 3. Baldessarini RJ, Perry R, Pike J. Factors associated with treatment nonadherence among US bipolar disorder patients. Hum Psychopharmacol, 2008; 23(2):95-105. DOI: https://doi.org/10.1002/hup.908
• 4. Berk L, Mcneil C, Castle D, Berk M. The importance of the treatment alliance in bipolar disorder. In Psychotherapies for the Psychoses, Gleeson JFM, Killackey E, Krstev H (Eds). Routledge: Britain.
• 5. Berk L, Hallan KT, Colom F, Vieta E, Hasty M, Macneil C, Berk M. Enhacing medication adherence in paients with bipolar disorder. Hum Psychopharmacol Clin Exp, 2010; 25:1-16. DOI: https://doi.org/10.1002/hup.1081
• 6. Buckley PF. Update on the treatment and management of schizophrenia and bipolar disorder. CNS Spectr, 2008; 13 suppl 11-10.10,quiz 11-12. DOI: https://doi.org/10.1017/S1092852900003126
• 7. Byerly M, Fisher R, Whatley K et al. A comparison of eletronic monitoring vs. Clinician rating of antipsychotics adherence in outpatients with schizophrenia. Psychiatry Res, 2005; 133:129-133. DOI: https://doi.org/10.1016/j.psychres.2004.11.002
• 8. Cochran SD. Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders. J Cônsul Clin Psychol, 1984; 52: 873-878. DOI: https://doi.org/10.1037//0022-006X.52.5.873
• 9. Colom F, Vieta E, Martinez-Aran A et al. A randomized Trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry, 2003; 60:402-407. DOI: https://doi.org/10.1001/archpsyc.60.4.402
• 10. Copeland LA, Zeber JE, Salloum IM, et al. Treatment adherence and illness insight in veterans with bipolar disorder. J Nerv Ment Dis, 2008; 196(1):16-21. DOI: https://doi.org/10.1097/NMD.0b013e318160ea00
• 11. Crowe M, Wilson L, Inder M. Patient’s reports of the factors influencing medication adhrence in bipolar disorder – An integrative review of the literature. Int J Nurs Stud, 2011; 48, 894-903. DOI: https://doi.org/10.1016/j.ijnurstu.2011.03.008
• 12. Depp CA, Lebowitz BD, Patterson TL, Lacro JP, Jeste DV. Medication adherence skills training for middle aged and elderly adults with bipolar disorder, development and pilot study. Bipolar Disorder, 2007; 9:636-645. DOI: https://doi.org/10.1111/j.1399-5618.2007.00397.x
• 13. Gianfrancesco FD, Sajatovic M, Rajagopalan K, et al. Antipsychotic treatment adherence and associated menal health care use among individuals with bipolar disorder. Clin Ther, 2008; 30(7):1358-1374. DOI: https://doi.org/10.1016/S0149-2918(08)80062-8
• 14. Gonzalez-Pinto A, Mosquera F, Alonso M, et al. Suicidal risk in bipolar I disorder patients and adhrence to long-term lithium treatment. Bipolar Disord, 2006; 8(5):618-624. DOI: https://doi.org/10.1111/j.1399-5618.2006.00368.x
• 15. Hirschfeld RM, Vornik LA. Bipolar disorder: costs and comorbidity. AM J Manag Care, 2005; 11(suppl 3):85-90.
• 16. Horne R, Weinman J, Hankins M. The beliefs about meicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychology and Health, 1999; 14, 1-24. DOI: https://doi.org/10.1080/08870449908407311
• 17. Horne R. Compliance, adhrence and concordance: implications fo asthma treatment. Chest, 2006; 130,56-72. DOI: https://doi.org/10.1378/chest.130.1_suppl.65S
• 18. Johnson FR, Ozdemir S, Manjunath R, et al. Factors that effect adherence to bipolar disorder treatments: a stated-preference approach. Med Care, 2007; 45(6):545-552. DOI: https://doi.org/10.1097/MLR.0b013e318040ad90
• 19. Kessler RC, Akiskal HS, Ames M, et al. Prevalence and effects of mood disorders on work performance in a nationally representative sample of US workers. Am J Psychiatry, 2006; 163(9):1561-1568. DOI: https://doi.org/10.1176/ajp.2006.163.9.1561
• 20. Miklowitz DJ, Johnson SL. The psychopathology and treatment of bipolar disorder. Annu Rev Clin Psychol, 2006; 2(1): 199-235. DOI: https://doi.org/10.1146/annurev.clinpsy.2.022305.095332
• 21. Peet M & Harvey NS. Lithium maintenance, 1. A standard education programme for patients. Br J Psychiatry, 1991; 158: 197-200. DOI: https://doi.org/10.1192/bjp.158.2.197
• 22. Pomykacz B, Mao M, Weiss RD, Teter CJ. A review of brief medication-adherence instrument used in patients with schizophrenia and bipolar disorder. Harv Rev Psychiatry, 2007; 15: 259-263. DOI: https://doi.org/10.1080/10673220701650383
• 23. Sajatovic M, Davies M, Hrouda DR. Enhancement of treatment adherence among patients with bipolardisorder. Psychiatr Serv, 2004; 55: 264-269. DOI: https://doi.org/10.1176/appi.ps.55.3.264
• 24. Sajatovic M. Bipolar disorder: disease burden. AM J Manag Care, 2005; 11(suppl 3): 85-90.
• 25. Sajatovic M, Valenstein M, Blow FC, et al. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord, 2006; 8(3):232-241. DOI: https://doi.org/10.1111/j.1399-5618.2006.00314.x
• 26. Sajatovic M, Valenstein M, Blow FC, et al. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr Serv, 2007a; 58(6):855-863. DOI: https://doi.org/10.1176/ps.2007.58.6.855
• 27. Sajatovic M, Chen PJ, Dines P, Shirley ER. Psychoeducational approaches to medication adhrence in patients with bipolar disorder. Dis Manag Health Out, 2007b; 15:181-192. DOI: https://doi.org/10.2165/00115677-200715030-00006
• 28. Scott J. Using health belief models to understand the efficacy-effectiveness gap for mood stabilizer treatments. Neurobiology, 2000; 46(Suppl 1):13-15. DOI: https://doi.org/10.1159/000068022
• 29. Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry, 2002; 63:384-90. DOI: https://doi.org/10.4088/JCP.v63n0502
• 30. Scott J & Tacchi MJ. A pilot study of concordance therapy for individuals with bipolar disorders Who are non-adherent with lithium prophylaxis. Bipolar Disord, 2002; 4: 386-392. DOI: https://doi.org/10.1034/j.1399-5618.2002.02242.x
• 31. Velligan DI, Weiden PJ, Sajatovic M, et al. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry, 2009; 70(Suppl 4): 1-46[quiz 47-8] DOI: https://doi.org/10.4088/JCP.7090su1cj
• 32. Vieta E. Improving treatment adherence in bipolar disorder through psychoeducation. J Clin Psychiatry, 2005; 66(Suppl 1): 24-29.
• 33. Zarate CA., Jr. Antipsychotic drug side effect issues in bipolar manic patients. J Clin Psychiatry, 2000(61suppl): 852-63. DOI: https://doi.org/10.4088/JCP.v61n0109
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2011 Erico de Castro Costa, Antônio Geraldo da Silva
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria permite que o (s) autor (es) mantenha(m) seus direitos autorais sem restrições. Atribuição-NãoComercial 4.0 Internacional (CC BY-NC 4.0) - Debates em Psiquiatria é regida pela licença CC-BY-NC
